Article info
Systemic lupus erythematosus
Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity
- Correspondence to Professor Emmanouil T Dermitzakis, Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland; Emmanouil.Dermitzakis{at}unige.ch; Dr Dimitrios T Boumpas, Biomedical Research Foundation of the Academy of Athens, Athens, Greece; boumpasd{at}uoc.gr
Citation
Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity
Publication history
- Received September 2, 2018
- Revised March 14, 2019
- Accepted March 16, 2019
- First published June 5, 2019.
Online issue publication
May 13, 2021
Article Versions
- Previous version (13 May 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.